Gastritis flemonosa aguda

A Patient With Good Syndrome Complicated With Phlegmonous Gastritis

“…1–3 Still, up to 50% of patients do not have a clearly identified risk factor. 2,3 Good syndrome, the risk factor for PG in our patient, occurs in patients in their 50s and 60s, equally affecting both genders. Its pathogenesis remains unknown, although evidence suggests both primary bone marrow and/or T cell defect.…”

Diagnosis and treatment of acute phlegmonous gastritis

“…Acute PG was originally described by Cruveilhier in the early 18th century, and an average of 1 case report per year has appeared over the last 60 years. [4–6] The disease affects all age groups and is highly common in adults in their 50s to 70s, and the male-to-female ratio is 2:1. [7] Acute PG is rare clinically, especially since the use of antibiotics, but becomes urgent and develops quickly once it occurs.…”

Phlegmonous Gastritis, About a Case

“…Phlegmonous gastritis is a rare disease of an acute nature with a mortality rate of approximately 50% (1). The most frequent isolated microorganism is Streptococcus pyogenes in 70% of cases, although escherichia coli, haemophilus influenzae, proteus and clostridium have also been identified (2)(3)(4)(5).…”

“…The most frequent symptoms are intense abdominal pain that is usually located in the epigastrium, which can be accompanied by vomiting, fever, diarrhea or hematemesis (3)(4)(5)(6). In about 50% of cases, they occur in previously healthy patients (1). However, risk factors have been described, including immunodeficiencies such as Human Immunodeficiency Virus (HIV), gastric carcinoma, chronic treatment with glucocorticoids, invasive procedures, diabetes mellitus, hepatitis B and C, and alcoholism (7).…”

“…However, risk factors have been described, including immunodeficiencies such as Human Immunodeficiency Virus (HIV), gastric carcinoma, chronic treatment with glucocorticoids, invasive procedures, diabetes mellitus, hepatitis B and C, and alcoholism (7). In turn, its route of transmission can be through the hematogenous, lymphatic, or by dissemination from another infected area (1).…”